Merck to create separate cancer business to offset Keytruda patent loss
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
